Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study ; volume:8 ; number:4 ; day:20 ; month:8 ; year:2021 ; pages:1551-1563 ; date:12.2021
Rheumatology and therapy ; 8, Heft 4 (20.8.2021), 1551-1563, 12.2021
- Urheber
-
Curtis, Jeffrey R.
Chakravarty, Soumya D.
Black, Shawn
Kafka, Shelly
Xu, Stephen
Langholff, Wayne
Parenti, Dennis
Greenspan, Andrew
Schwartzman, Sergio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-021-00354-4
- URN
-
urn:nbn:de:101:1-2022012019015627621320
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Curtis, Jeffrey R.
- Chakravarty, Soumya D.
- Black, Shawn
- Kafka, Shelly
- Xu, Stephen
- Langholff, Wayne
- Parenti, Dennis
- Greenspan, Andrew
- Schwartzman, Sergio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Predictors of infusion reactions during infliximab treatment in patients with arthritis
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate
Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting
Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
Specific immunosuppression by postoperative intravenous infusion of allogeneic leukocytes
Intravenous infusion route in maternal resuscitation: a scoping review
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
Premedication with intravenous steroids does not influence the incidence of infusion reactions following infliximab infusions in pediatric inflammatory bowel disease patients—a case-control study
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Predictors of infusion reactions during infliximab treatment in patients with arthritis
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate
Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting
Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
Specific immunosuppression by postoperative intravenous infusion of allogeneic leukocytes
Intravenous infusion route in maternal resuscitation: a scoping review
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
Premedication with intravenous steroids does not influence the incidence of infusion reactions following infliximab infusions in pediatric inflammatory bowel disease patients—a case-control study
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Predictors of infusion reactions during infliximab treatment in patients with arthritis
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate
Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting
Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
Specific immunosuppression by postoperative intravenous infusion of allogeneic leukocytes
Intravenous infusion route in maternal resuscitation: a scoping review
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients